CLIN2 Awards: Funding Opportunity for Clinical Trials

About this program

The California Institute for Regenerative Medicine (CIRM) CLIN2 Awards fund clinical development of stem cell–based and genetic therapies for diseases with unmet medical needs, with the goal of accelerating candidates toward late‑stage trials and promoting equitable access. Projects must present a comprehensive clinical development strategy aimed at obtaining marketing approval, employ innovative trial designs with participant demographics representative of the broader patient population, and include stage‑appropriate pre‑commercialization planning to ensure accessibility and affordability. Applications are submitted via CIRM’s Grants Management Portal, are accepted quarterly, and the next deadline is January 30, 2026 (2:00 PM PST); consult the CLIN2 Program Announcement (updated May 15, 2025) and the CLIN2 Awards web page for full eligibility and review criteria.